EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Approaches for Mitochondrial Diseases

Seongho Hong iD, Sanghun Kim, Kyoungmi Kim iD, Hyunji Lee

Cells · 2023

DOI: 10.3390/cells12202494 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Seongho Hong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Korea Mouse Phenotyping Center, Seoul National University, Seoul 08826, Republic of Korea. Hauptthemen laut MEDLINE: Mitochondrial Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria are subcontractors dedicated to energy production within cells. In human mitochondria, almost all mitochondrial proteins originate from the nucleus, except for 13 subunit proteins that make up the crucial system required to perform ‘oxidative phosphorylation (OX PHOS)’, which are expressed by the mitochondria’s self-contained DNA. Mitochondrial DNA (mtDNA) also encodes 2 rRNA and 22 tRNA species. Mitochondrial DNA replicates almost autonomously, independent of the nucleus, and its heredity follows a non-Mendelian pattern, exclusively passing from mother to children. Numerous studies have identified mtDNA mutation-related genetic diseases. The consequences of various types of mtDNA mutations, including insertions, deletions, and single base-pair mutations, are studied to reveal their relationship to mitochondrial diseases. Most mitochondrial diseases exhibit fatal symptoms, leading to ongoing therapeutic research with diverse approaches such as stimulating the defective OXPHOS system, mitochondrial replacement, and allotropic expression of defective enzymes. This review provides detailed information on two topics: (1) mitochondrial diseases caused by mtDNA mutations, and (2) the mechanisms of current treatments for mitochondrial diseases and clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial DiseasesChildHumansMitochondriaDNA, MitochondrialOxidative PhosphorylationMutation

Stichwörter der Autor:innen

clinical trialsmitochondrial diseasesmitochondrial therapy

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Korea Mouse Phenotyping Center, Seoul National University, Seoul 08826, Republic of Korea.
  • Department of Medicine, Korea University College of Medicine, Seoul 02708, Republic of Korea.
  • Laboratory Animal Resource and Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 28116, Republic of Korea.
  • College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.
  • Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Department of Physiology, Korea University College of Medicine, Seoul 02841, Republic of Korea.

ORCID-Profile: Seongho Hong, Kyoungmi Kim

Förderung

  • National Research Foundation of Korea (NRF)

Zitieren

APA

Hong, S., Kim, S., Kim, K., & Lee, H. (2023). Clinical Approaches for Mitochondrial Diseases. Cells. https://doi.org/10.3390/cells12202494

Vancouver

Hong S, Kim S, Kim K, Lee H. Clinical Approaches for Mitochondrial Diseases. Cells. 2023. doi:10.3390/cells12202494

BibTeX
@article{Hong2023,
  author = {Hong, Seongho and Kim, Sanghun and Kim, Kyoungmi and Lee, Hyunji},
  title = {Clinical Approaches for Mitochondrial Diseases},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12202494}
}
Kostenlos starten →